GAZYVA

GAZYVA

GAZYVA INJECTION
Salt Composition : OBINUTUZUMAB
Manufacturer : ROCHE PRODUCTS INDIA PVT LTD

Available in Package:
GAZYVA 1000 mg Injection (1 Vial Of 40ml): MRP
: ₹399305
Prescription Required
Cold Chain Product
There is a Patient Support Program/Patient Assistance Program available in India for this medicine. The program aims to provide eligible patients with access to the medication at a more affordable cost . Please contact your prescribing doctor to know more about the same. You may also call on (9205022032) for more details.

 

Product Description

GAZYVA is an anti-cancer medicine that contains the active substance Obinutuzumab. It is used alone and in combination with the other chemotherapy drug for the treatment of Chronic Lymphocytic Leukaemia (CLL) and Follicular Lymphoma (FL). It belongs to a group of medicines called monoclonal antibodies, works by inhibiting the B-cell lymphocytes that are responsible for the multiplication of cancer cells.. This slows the growth of cancer cells and eventually kills them.
However, the uses of the medicine mentioned are not exhaustive; there may be other reasons or situations in which the medicine might be used.

Inform the doctor if you have any pre-existing or a history of liver/kidney disease, heart disease, active infections, breathing problems, weak immune system, brain disorders, eye disorders and skin problems.

Inform the doctor about all your medical conditions, prescription and non-prescription drugs, vitamin supplements, herbal medications, since GAZYVA can interact with them. GAZYVA can cause an allergic reaction in some patients therefore it is necessary to read the complete composition list and consult the doctor in case of any ingredient that induces allergies.

Consult the doctor if you are planning, on a pregnancy or breastfeeding.
It is advisable to avoid driving and operating heavy machinery during the course of GAZYVA.

Indications of GAZYVA

GAZYVA indicated alone and in combination with the other chemotherapy drug for the treatment of patients with Chronic Lymphocytic Leukaemia (CLL), a type of cancer that occurs in the bone marrow and blood and Follicular Lymphoma (FL) or called as non-Hodgkin’s lymphoma (NHL), a type of cancer that affect a specific type of WBC called B-lymphocytes.

Therapeutic Effects of GAZYVA

GAZYVA contains Obinutuzumab, which belongs to the class of CD20-directed cytolytic antibodies.
It works by binding to the CD20 antibody and causes lysis of B-cell lymphocytes responsible for the multiplication of cancer cells. This causes shrinkage of tumour cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells.

Directions for Use

GAZYVA Injection is usually given as an intravenous injection. Do not administer as an intravenous push or bolus. The dosage and duration of treatment will depend on the individual’s condition and response to the medication and should be determined by the doctor.
Your doctor will decide the dose and frequency of administration based on your health condition.
A trained healthcare doctor will administer GAZYVA. So, do not self-administer.

Storage

GAZYVA Injection should be stored in refrigerator at 2°C to 8°C.Do not freeze. Do not shake.
If you are traveling, carefully follow all patient instructions for storing your medicine during travel.Avoid extreme heat or cold.
Keep in the original container to protect from light and moisture.
Keep GAZYVA Injection out of sight and reach of children.

Common:

Serious:

Tell a doctor or nurse straight away, if you notice any of the side effects above.

Contraindications

GAZYVA is contraindicated in patients with a known hypersensitivity to GAZYVA or any of the excipients.

Drug Interactions

GAZYVA might interact with other medicines. Therefore, it is recommended to inform your doctor about all the prescriptions you have.

Safety Advices for GAZYVA

Consult Your Doctor

It is unknown whether GAZYVA interacts with alcohol. However, it is best to avoid alcohol or limit your alcohol consumption while taking any medication. Consult your doctor if you have history of Alcohol intake.

Consult Your Doctor

GAZYVA is not recommended for use in pregnancy as it may harm your fetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before taking GAZYVA Injection. Using effective birth control methods while on treatment is suggested.

Consult Your Doctor

Avoid breastfeeding your baby while on the treatment with GAZYVA, as it may pass through breast milk. Consult your doctor if you are breastfeeding before taking this medication.

Unsafe

No studies on the effects of GAZYVA on the ability to drive and to use machines have been performed. However , avoid driving or operating machines that require mental concentration until you are not alert

Consult Your Doctor

If you have any lung-related symptoms, consult your doctor before taking this medicine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Consult Your Doctor

If you have a pre-existing or a history of liver problems, consult your doctor before taking this medicine. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Consult Your Doctor

If you have a pre-existing or a history of kidney disease, inform your doctor. Your doctor may adjust the dose of this medicine or prescribe a suitable alternative based on your condition.

Consult Your Doctor

GAZYVA is not recommended for use in children below 18 years of age as the safety and efficacy are not established.

 

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our ‘Platform’, we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user’s risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship. All Trademarks, Brands and Service marks that appear on this website belong to their respective owner.

 

Obinutuzumab

Obinutuzumab Gazyva

Cold Chain Product